Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy

<table>Anterior (a) and posterior (b) planar gamma camera images of radiolabeled J591. A greater number of lesions are apparent compared to anterior (c) and posterior (d) <sup>99m</sup>Tc-MDP bone scan. Hepatic clearance of radiolabeled mAb results in nonspecific uptake in the liver.</table>

Advances in Urology

fig1

Figure 1

Figure 1: Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy 

Figure 1 | Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy 